Company / Current Liabilities
Neogen Current Liabilities History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$174.0M
FY2025
5-year range
$53.6M / $174.0M
FY2021-FY2025
Trend
+12.8%
vs FY2024
Sector context
#111 of 165
Health Care
What the data says
At $174M, Neogen's current liabilities ranks #55 of 165 in the Health Care sector. Current Liabilities has increased for 6 consecutive years, from $38M in FY2019 to $174M in FY2025.
Based on SEC 10-K filings.
$174M in FY2025 with a 5-year CAGR of +29.1%.
Increased from $145M to $174M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +30.8%
- 5-Year CAGR
- +29.1%
- 10-Year CAGR
- -
Sector benchmark
#55 of 165 in Health CareTop 33% of 165This company $174.0M Sector average $4.4B
▼
-96.0% below sector average
Key checks
Key Insights
- Neogen's current liabilities has grown for 6 consecutive years.
- 5-year CAGR of +29.1%, indicating consistent growth.
- In FY2025, current liabilities increased 12.8% year-over-year.
- Ranks #111 out of 165 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score 0.59 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $174.0M | +12.8% |
| FY2024 | $154.3M | +6.1% |
| FY2023 | $145.5M | +86.9% |
| FY2022 | $77.8M | +45.2% |
| FY2021 | $53.6M | +10.5% |
| FY2020 | $48.5M | +26.8% |
| FY2019 | $38.3M | -1.1% |
| FY2018 | $38.7M | +7.5% |
| FY2017 | $36.0M | +25.9% |
| FY2016 | $28.6M | +12.3% |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026